Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.

@article{Persson2007ElevatedLL,
  title={Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.},
  author={Margaretha Persson and Bo Hedblad and Jeanenne J. Nelson and G{\"o}ran GB Berglund},
  journal={Arteriosclerosis, thrombosis, and vascular biology},
  year={2007},
  volume={27 6},
  pages={1411-6}
}
BACKGROUND To explore potential interrelationships between lipoprotein-associated phospholipase A2 (Lp-PLA2), the metabolic syndrome (MetS), and incident cardiovascular disease (CVD). METHODS AND RESULTS MetS was defined by the National Cholesterol Education Program Adult treatment Panel III criteria in 4480 nondiabetic Malmö Diet and Cancer Study subjects without history of CVD. Incidence of first CVD event (stroke [130 cases] or myocardial infarction [131]) was monitored over 10 years of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 74 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Heiss G. the metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study

  • AM McNeill, WD Rosamund, +4 authors CM Ballantyne
  • Diabetes Care
  • 2005

Similar Papers

Loading similar papers…